CareFirst opposes judgment against US antitrust claims against Johnson & Johnson
MLex Summary: CareFirst opposed Johnson & Johnson and Janssen Biotech’s motion for judgment in a US antitrust case over Stelara, arguing a reasonable jury could find in favor of the plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article